Teza Capital Management LLC Haemonetics Corp Transaction History

Teza Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Feb 22, 2024	BUY	$80.84 - $89.45 $612,605 - $677,852	7,578 New	7,578 $645,000
Q2 2023 Aug 14, 2023	BUY	$80.84 - $89.45 $747,365 - $826,965	9,245 Added 366.28%	11,769 $1 Million
Q1 2023 May 15, 2023	BUY	$72.75 - $90.6 $183,621 - $228,674	2,524 New	2,524 $208,000
Q3 2022 Nov 14, 2022	BUY	$63.3 - $78.66 $180,405 - $224,181	2,850 New	2,850 $211,000
Q3 2020 Nov 12, 2020	SELL	$75.65 - $93.58 $327,413 - $405,014	-4,328 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$84.96 - $118.91 $367,706 - $514,642	4,328 New	4,328 $388,000
Q1 2020 May 11, 2020	SELL	$74.34 - $121.82 $226,142 - $370,576	-3,042 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$114.37 - $129.46 $347,913 - $393,817	3,042 New	3,042 $350,000
Q3 2018 Nov 14, 2018	SELL	$89.96 - $114.58 $321,337 - $409,279	-3,572 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$71.53 - $95.75 $255,505 - $342,019	3,572 New	3,572 $320,000

333

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.21B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Teza Capital Management LLC with notifications on news.